Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced Ryoncil ® (remestemcel-L-rknd) net revenue of US$36 million for the ...

But the evidence indicates people should focus on diet quality, not just calorie quantity. Avoid ultra-processed foods, ...

The STEM-PD research team will now continue the long-term follow-up of the participants to further evaluate safety, graft function, and clinical benefit.

Vera Therapeutics faces tough IgAN competition as Trutakna looks late and undifferentiated. A rich valuation adds risk. Read ...

A landmark study led from Lund, Sweden, has shown that transplanting stem-cell derived dopamine progenitor cells into the ...

Dalbavancin has been utilized for long-term suppressive antibiotic therapy for complicated gram-positive infections in ...

Next-generation instruments improve rare-cell detection, sterility control, biosafety, and throughput for translational ...

Opus Genetics, Inc. (Nasdaq: IRD) (the “Company”, “Opus Genetics” or “Opus”), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients ...

Children and adults with relapsed or refractory T-cell acute lymphoblastic leukemia now have a new reason to pay attention.

These letters stand for the French words conformité européenne, which means "European conformity" in English. Its presence ...